| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/31/1997 | WO1997026867A2 Solid instant-release forms of administration and process for producing the same |
| 07/31/1997 | WO1997026866A2 Preparations of non-steroidal analgesics |
| 07/31/1997 | WO1997026864A2 Methods and compositions for enhancing the bioadhesive properties of polymers |
| 07/31/1997 | WO1997026862A2 Improved concentrated injection and infusion solutions for intravenous administration |
| 07/31/1997 | WO1997026803A1 Water dispersible compositions containing natural hydrophilic, water-insoluble pigments, methods of preparing same and their use |
| 07/31/1997 | WO1997026802A1 Water dispersible compositions containing natural hydrophobic pigment, method of preparing same and their use |
| 07/31/1997 | WO1997018790A3 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 07/31/1997 | WO1997015269A3 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 07/31/1997 | WO1997011719A3 Stereoselective delivery of chiral compounds |
| 07/31/1997 | DE19602757A1 Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung Fixed instant release dosage forms and methods for their preparation |
| 07/31/1997 | CA2244843A1 Avermectin formulation |
| 07/31/1997 | CA2243964A1 Solid instant-release forms of administration and processes for their production |
| 07/31/1997 | CA2243825A1 Obesity protein analog compounds and formulations thereof |
| 07/31/1997 | CA2243533A1 Ligand directed enzyme prodrug therapy |
| 07/31/1997 | CA2241319A1 Highly concentrated, lyophilized, and liquid factor ix formulations |
| 07/30/1997 | EP0786526A2 Lactose spherical particles and process for their production |
| 07/30/1997 | EP0786469A2 Nucleic acid ligands |
| 07/30/1997 | EP0786251A2 Topical preparation containing a suspension of solid lipid particles |
| 07/30/1997 | EP0786088A2 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 07/30/1997 | EP0786010A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins |
| 07/30/1997 | EP0785990A1 Method for stimulating profileration of colon cells using pomc 76-103 |
| 07/30/1997 | EP0785920A1 Multifunctional cross-linking reagents for hemoglobin, and cross-linked hemoglobin conjugates |
| 07/30/1997 | EP0785802A1 Saponin preparations and use thereof in iscoms |
| 07/30/1997 | EP0785801A1 Treatment of tissues to reduce subsequent response to injury |
| 07/30/1997 | EP0785798A1 Formulations comprising therapeutically-active proteins or polypeptides |
| 07/30/1997 | EP0785797A1 A pharmaceutical formulation comprising a growth hormone and leucine |
| 07/30/1997 | EP0785796A1 A pharmaceutical formulation comprising a growth hormone and isoleucine |
| 07/30/1997 | EP0785795A1 A pharmaceutical formulation comprising a growth hormone and valine |
| 07/30/1997 | EP0785783A1 Sabeluzole oral suspensions |
| 07/30/1997 | EP0785776A1 Preparation of protein microspheres, films and coatings |
| 07/30/1997 | EP0785775A1 Melt-extruded orally administrable opioid formulations |
| 07/30/1997 | EP0785773A1 Ether lipid liposomes and their therapeutic use |
| 07/30/1997 | EP0785772A1 Lyophilizate of lipid complex of water insoluble camptothecins |
| 07/30/1997 | EP0785770A1 Hemorrhoidal compositions and method of use |
| 07/30/1997 | EP0609221B1 Antimicrobial dialdehyde composition and methods of use |
| 07/30/1997 | EP0533809B1 Polyurethane-biopolymer composite |
| 07/30/1997 | EP0303713B2 Percutaneous absorption promoter and dermatologic preparation for external use |
| 07/30/1997 | CN1155844A Iron-containing nanoparticles with double coating and their use in diagnosis and therapy |
| 07/30/1997 | CN1155842A Novel composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods |
| 07/30/1997 | CN1155836A Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives |
| 07/30/1997 | CN1155835A Oestradiol transdermal therapeutic system comprising hydroscopic additives |
| 07/30/1997 | CN1155417A Oral formulations of S(+)-ibuprofen |
| 07/30/1997 | CN1155382A Wide spectrum disinfective agent |
| 07/29/1997 | US5652361 Macrocyclic ligands and complexes |
| 07/29/1997 | US5652319 Low-odor, higher molecular weight polyether polyols, a process for producing them, and their use for the production of polymers, cosmetics and pharmaceutical products synthesized from polyether polyols |
| 07/29/1997 | US5652267 Method of using saccharic acid or saccharolactone for treating wrinkles |
| 07/29/1997 | US5652263 Retinoid compositions containing a water soluble antioxidant and a chelator |
| 07/29/1997 | US5652256 Naftifine hydrochloride gel containing methyl acetate penetration enhancing compound |
| 07/29/1997 | US5652216 Pharmaceutical preparation |
| 07/29/1997 | US5652212 Cyclosporin galenic forms |
| 07/29/1997 | US5652122 Nucleic acids encoding and methods of making tat-derived transport polypeptides |
| 07/29/1997 | US5652110 Antibodies to αvβ3 integrin |
| 07/29/1997 | US5652109 Antitumor agents; medical diagnosis |
| 07/29/1997 | US5651989 Iron/carbon particles for drug delivery, using an external magnetic field to direct drug to target area inside body |
| 07/29/1997 | US5651987 Ulcer prevention and treatment composition |
| 07/29/1997 | US5651986 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 07/29/1997 | US5651985 Expandable pharmaceutical forms |
| 07/29/1997 | US5651983 Bisacodyl dosage form for colonic delivery |
| 07/29/1997 | US5651982 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| 07/29/1997 | US5651979 Apparatus and method for delivering a biologically active compound into a biological environment |
| 07/29/1997 | US5651973 Therapeutically effective topical application of ST1435 |
| 07/29/1997 | US5651971 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents |
| 07/29/1997 | CA1339122C Crosslinked carboxy polysaccharides |
| 07/29/1997 | CA1339082C Directly compressible sustained release excipient |
| 07/29/1997 | CA1339081C Delayed release formulations |
| 07/29/1997 | CA1339074C Process for the production of collagen foams in the form of continuous tapes and their use in medicine, cosmetics and hygiene |
| 07/29/1997 | CA1339073C Penetration enhancement with binary system of cell envelope disordering compounds & lower alcohols |
| 07/24/1997 | WO1997026275A1 Protein occlusion for delivery of small molecules |
| 07/24/1997 | WO1997026015A1 Sustained release drug formulations |
| 07/24/1997 | WO1997026012A1 Obesity protein formulations |
| 07/24/1997 | WO1997026011A1 Obesity protein formulations |
| 07/24/1997 | WO1997026004A1 Obesity protein formulations |
| 07/24/1997 | WO1997026003A1 Cyclosporin formulation |
| 07/24/1997 | WO1997025990A1 High-content famciclovir tablets |
| 07/24/1997 | WO1997025977A1 Pharmaceutical compositions |
| 07/24/1997 | WO1997025976A1 Anthelmintic paste |
| 07/24/1997 | WO1997025973A1 Compositions for treating hair or skin |
| 07/24/1997 | WO1997025968A1 Film coating composition for whitening teeth |
| 07/24/1997 | WO1997025959A2 Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts |
| 07/24/1997 | WO1997015668A3 Methods and compositions comprising glut-2 and glut-2 chimeras |
| 07/24/1997 | WO1997006176A3 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 07/24/1997 | DE19602206A1 Zubereitungen nichtsteroidaler Analgetika Preparations of non-steroidal analgesics |
| 07/24/1997 | CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives |
| 07/24/1997 | CA2243518A1 Obesity protein formulations |
| 07/24/1997 | CA2243512A1 Obesity protein formulations |
| 07/24/1997 | CA2243229A1 Obesity protein formulations |
| 07/23/1997 | EP0785252A1 Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer |
| 07/23/1997 | EP0784984A2 Transfection competent molecules |
| 07/23/1997 | EP0784982A2 Obesity protein formulations |
| 07/23/1997 | EP0784981A2 Obesity protein formulations |
| 07/23/1997 | EP0784979A2 Obesity protein formulations |
| 07/23/1997 | EP0784972A2 Cosmetic and/or pharmaceutical emulsions |
| 07/23/1997 | EP0784689A1 Microorganisms as therapeutic delivery systems |
| 07/23/1997 | EP0784683A1 Tie-2 ligands, methods of making and uses thereof |
| 07/23/1997 | EP0784506A1 Method of coating particles |
| 07/23/1997 | EP0784487A1 A composition and a method for tissue augmentation |
| 07/23/1997 | EP0784485A1 Vaccine compositions |
| 07/23/1997 | EP0784481A1 Wound healing formulations containing human plasma fibronectin |
| 07/23/1997 | EP0784474A2 Parenteral pharmaceutical compositions containing gf120918a |
| 07/23/1997 | EP0784469A1 Compositions for the delivery of antigens |